FTC OKs $500M Valeant-PreCision Deal With Acne Drug Sales

FTC OKs $500M Valeant-PreCision Deal With Acne Drug Sales

The Federal Trade Commission agreed Thursday to sign off on Valeant Pharmaceutical International Inc.'s $500 million acquisition of PreCision Dermatology Inc. on the condition that the companies sell the rights to some of the skin care company's ...read more

  • Tags: